Good morning dispensers of wisdom!

Canada’s pharmacy sector is proving it’s doing a whole lot more than counting tablets and chasing fax machines. A new report found that pharmacies contribute nearly $23 billion to Canada’s economy and support more than 273,000 jobs across the country — from pharmacists and technicians to the many people who keep the system running behind the scenes. But the real story isn’t just the numbers. It’s the millions of patient interactions, expanded services, and moments where pharmacy teams step in to fill gaps when the healthcare system is stretched. Turns out, the place your patients visit for a prescription refill is one of the most important healthcare touchpoints in the country.

Today’s issue takes 5 minutes to read. Only got 1? Here’s what to know:

  • 🥚 Rituximab shows promise for autoimmune infertility.

  • 🦠 Rapid PCR testing speeds up nursing home treatment.

  • 👅 GLP-1s may dull your sense of taste.

  • Health Canada approves Vanrafia for IgA nephropathy.

  • 🤖 AI prescription refills spark a safety debate.

  • ⚽ Soccer’s hidden brain health risks.

  • 🦠 Cyclospora outbreak linked to produce.

  • 🌶️ Heavy chili intake linked to GI cancer risk.

Let’s get into it.

Staying #Up2Date 🚨

1: Can Rituximab Put a Stop to Primary Ovarian Insufficiency?

A proof-of-concept study of women with autoimmune premature ovarian insufficiency (POI) assessed whether rituximab could enhance ovarian responsiveness to hormones and restore fertility. In women aged 18 to 35 years who had not previously responded to ovarian hyperstimulation therapies, rituximab helped half of the group achieve follicular development that led to oocyte retrieval. From there, some were able to deliver healthy children via IVF. A randomized controlled trial is needed to further evaluate the safety and efficacy of rituximab in women with autoimmune POI trying to conceive.

2: The Value of Rapid Diagnosis Beyond Outbreak Control

A cluster randomized trial of 20 nursing homes found that using a point-of-care PCR instrument increased testing, improved case detection, and shortened time to antiviral therapy initiation for residents with respiratory virus infections, including SARS-CoV-2, influenza, and RSV. However, seasonal adoption of the on-site test did not reduce the number or size of outbreaks. Nevertheless, the intervention was estimated to avoid 4 hospital transfers per 100 nursing home beds, which could make a meaningful difference in health care utilization during peak-capacity periods.

3: Do GLP-1s Dull Your Sense of Taste (But Not Smell)?

A case-control study from the University of Pennsylvania's Smell and Taste Center tested 46 adults on GLP-1 receptor agonists against 46 matched controls. Taste perception was significantly impaired across all 5 basic qualities, with 85% of GLP-1 users scoring worse than controls. Smell was only slightly reduced and not statistically significant. Oddly, those with GI side effects like nausea and diarrhea scored better on both tests. The mechanism is unknown but may involve GLP-1 receptors in the brainstem or vagus nerve pathways. It's worth flagging for patients who report changes in appetite or food enjoyment while on these medications.

Shelf Watch 🏥

Drug Shortages ⚠️

  • Company: Merck Canada

  • Drug class: Blood glucose lowering drugs, excl. insulins (DPP-4 inhibitor + biguanide)

  • DIN: 02416794 (50 mg/1000 mg) / 02416808 (100 mg/1000 mg)

  • Strengths affected: 50 mg/1000 mg, 100 mg/1000 mg

  • Shortage status: Anticipated shortage

  • Reason for shortage: Disruption of the manufacture of the drug.

  • Start date: 2026-08-24 (50 mg/1000 mg) / 2026-08-17 (100 mg/1000 mg)

  • Estimated end date: 2026-09-04 (50 mg/1000 mg) / 2026-09-11 (100 mg/ 1000 mg)

  • Company: Leo Pharma

  • Drug class: Antithrombotic agents

  • DIN: 02167840 (10,000 unit/mL)

  • Strengths affected: 10,000 unit/mL (2 mL vials)

  • Shortage status: Anticipated shortage

  • Reason for shortage: Disruption of the manufacture of the drug.

  • Start date: 2026-07-10

  • Estimated end date: 2026-08-03

Newly Approved Drugs

Vanrafia: proteinuria reduction in adults with primary immunoglobulin A nephropathy (IgAN) at risk of rapid disease progression, generally a urine protein-to-creatinine ratio (UPCR) ≥1.5 g/g.

  • NOC date: 2026-07-02

  • Submission type: New Drug Submission (NDS), New Active Substance (NAS)

  • Manufacturer: Novartis Pharmaceuticals Canada

  • Product type: Atrasentan (atrasentan hydrochloride) 0.75 mg

  • Dosage form: Tablet (oral once daily)

The Robot Rx Refill 🤖

Is artificial intelligence ready to take over your prescription pad?

What happened: A prescription refill program that quietly launched in Utah in January 2026 has ignited a medical-legal debate. The pilot program allows patients to skip doctor visits and get their routine medications renewed online through an AI chatbot called Doctronic. Operating under Utah’s "regulatory sandbox" (a system that allows state officials to waive medical licensing laws for promising technology companies) the chatbot verifies patient identities, checks active prescriptions against a national pharmacy database, and routes approved renewals directly to local pharmacies.

The program currently operates on a state-approved formulary of 190 medications, which excludes controlled substances, ADHD drugs, and injectables. However, the medical community is pushing back. In March 2026, Utah’s medical licensing board sent a formal letter demanding the pilot be halted, and the American Medical Association warned that "prescription renewals aren't routine checkboxes". Physicians argue that seemingly stable patients frequently have shifting health profiles; for example, renewing high-risk blood thinners like Eliquis or Xarelto on the formulary can become highly dangerous if a patient has recently developed stomach ulcers or other bleeding risks.

The pharmacist’s take: As a Canadian pharmacist, this might seem like a distant American experiment, but it could be a preview of the systemic pressures coming to your dispensary. While Canadian pharmacy teams are facing massive primary care demands and are looking to technology to ease administrative workloads, a major clinical trust gap remains. According to the industry-wide TELUS Health 2026 Pharmacy Trends Report, while 47% of Canadian pharmacists view AI integration as the single biggest driver of change in their sector, only 3% actually use AI tools regularly, with 62% citing unreliable outputs as their primary barrier to adoption.

The Utah controversy highlights exactly why this clinical skepticism exists. Medical experts, including Utah's medical licensing board chair Dr. Alan Smith, point out refills are rarely simple checkboxes. Because an AI chatbot cannot physically evaluate a patient's current health status, automated systems risk missing these critical shifts, leaving the dispensing pharmacist as the final human safety checkpoint.

Bottom Line: While AI offers significant potential to streamline prescription logistics, medical boards and pharmacy reports agree that the technology still faces a major trust and safety gap. Automatically renewing high-risk medications without human clinical evaluation introduces substantial safety risks that automated databases are not yet equipped to catch.

Hot Off The Press 🗞️

1: ⚽ As the World Cup heads toward the finals, a study from the Alzheimer’s Association International Conference is putting soccer’s long-term brain health risks under the microscope. Retired professional soccer players were more likely to report anxiety, depression, and problems with thinking or decision-making compared with people who hadn’t played contact sports. While some may not think of soccer the same way they think of American football, researchers say repeated head impacts, including headers, may affect brain health over time. Brain scans also showed lower grey matter in regions tied to memory, attention, and emotional regulation, though the findings are still preliminary.

2: 🍓 Thinking about picking your own produce this summer? You may want to watch out for an outbreak of a diarrhea-causing parasite. Cyclospora is a microscopic parasite that infects the bowels and is commonly linked to contaminated fresh fruits, vegetables, and herbs. More than 1,500 people in Michigan have been diagnosed, with similar illnesses being investigated in 30 other states, and officials still haven’t identified the exact source. Experts recommend basic hygiene, including washing hands with soap and water, since alcohol-based sanitizer doesn’t kill Cyclospora.

3: 🫁 The last American to rely on an iron lung has died. Martha Lillard, diagnosed with polio at age 5, passed away at 78 in Oklahoma, closing out a chapter of medical history. She'd spent the past 2 years in the machine nearly around the clock as her lung capacity dropped below 25%, a decline her family ties to long-haul COVID. Her sister says doctors never expected her to live past 20. Instead, she went to school over an intercom, learned to drive, got married this past February. Polio was declared eliminated in the US in 1979 (1995 in Canada) thanks to vaccination, making Lillard one of the last living links to an era when the disease paralyzed thousands of children a year.

4: 🌶️ Bad news for spice lovers. A meta-analysis pooling 14 studies and over 11K participants found that the highest chili pepper consumers had a 64% higher risk of gastrointestinal cancers overall, with esophageal cancer showing the strongest link, nearly 3 times the risk versus the lowest consumption group. Stomach and colorectal cancers showed no statistically significant increase. Risk also varied by region, with Asia, Africa, and North America showing higher associations while Europe and South America didn't. Researchers stress this is observational data only, so it can't prove chili peppers cause cancer, and it's still unclear whether moderate consumption carries the same risk as heavy use.

RxBriefly Picks 💊

📚 Learn: how the GLP-1 landscape is shifting beyond the scale. This 1-hour webinar with Dr. Sean Wharton unpacks the new therapeutic entries reshaping patient access and makes the case for treating GLP-1s as a total metabolic health play, not just a weight loss tool.

🥒 Make: this cucumber salad that turns thinly sliced cucumbers and red onion into a cool, with a tangy summer side. A quick honey vinegar dressing and a fresh finish of dill and chives.

✈️ Save: on a flight to Seoul. WestJet has dropped prices on nonstop Calgary to Seoul flights to $683 CAD roundtrip, about 58% below typical fares, with carry-on luggage still included.

📖 Read: about whether liquid biopsies could finally answer if cancer is really gone. This CBC piece follows a Toronto trial testing blood-based tumour DNA detection in 7,000 cancer survivors, and the ethical questions that come with knowing too soon.

🎥 Watch: the moment a CN Rail crew found themselves surrounded by a wall of flames in Northern Ontario. This harrowing video captures just how quickly wildfires can change, with fire on both sides of the tracks and crews racing to safety near Armstrong, Ont.

@solmamakwa

What we are witnessing right now in northern Ontario is devastating. This is near Armstrong, Ontario. When will the Canadian National Ra... See more

Relax 🧩

First clue: Life ___

Need a rematch? We’ve got you covered. Check out our Crossword Archive to find every puzzle we’ve ever made, all in one place.

Think you crushed it? Challenge your pharmacist friends to beat your time.

What Pharmacists Had to Say 💡

Meme Of The Week 😂

Advertise with RXBriefly 📣

Want to reach thousands of Canadian pharmacists every week? Email [email protected] to learn more.

Help Us Get Better 🙏

That’s all for this issue.

Cheers,

The RxBriefly team.

Keep Reading